All Episodes

A CDMO Roundtable: The Making of a Molecule: Peptide Synthesis

What Tops the Industry’s Sustainability Agenda for 2026?

2026 Outlook: CDMO Market for Injectables

2026: Drugs To Watch: The Year Ahead

2025: The Bio/Pharma Industry’s Year in Review

What’s Trending: ADCs: Pipelines, Products, & CDMO Growth

Drug Launches & Approvals in 2025: The Blockbuster Contenders

CDMOs-Injectables: Tariff Impact: Are Capacity Shifts in the Making?

Headwinds or Tailwinds: Will the Biotech Sector Rebound in 2025?

Global API Outlook: Will Supply Lines Change Amid Tariff Uncertainty?

Biomanufacturing: How are Industry Capacity & Supply Chains Trending?

Parenteral Drug Mfg—CDMO Outlook: a Capacity Crunch of Easing?

Bio/Pharma Industry Outlook, Supply Chains 2025: The Year Ahead

What’s Trending: Parenteral Drug Development & Manufacturing

CDMOs/CMOs: The Movers and Shakers of 2023

CDMO/CMO Mid-Year Review: Tracking the Key Moves Thus Far in 2023

API Alert: EU Proposes New Requirements To Secure Pharma Supply Chains

The CDMO/CMO Report: Parenteral Drugs

Drug Products: Key Trends & Recent Approvals

CDMOs/CMOs Expand High-Potency API Manufacturing

Incorporating Sustainability into the Bio/Pharma Supply Chain: Where Does the Industry Stand?

CDMOs/CMOs Ramp Up Biomanufacturing Capacity

How Can Today’s Supply-Chain Challenges Be Fixed?

Parenteral Drugs: CDMOs/CMOs Expanding

Rising Energy Costs and API Supply

Blockbuster Muscle: Small Molecules or Biologics?

Injectable and Solid Dosage Drug Delivery: Key Deals

Mid-Year CDMO Review: COVID-19 Vaccine Manufacturing and M&A

FDA Addresses Supply Constraints Due to COVID-19; Plus, Packaging Suppliers Expand

The Year in Review: 2020

Company on the Move: Viatris

Solid-Dosage Mfg: CDMO Market and Product Trends

Top 10 Watch List: Pharma CEOs on the Rise

The Pipeline Contenders: What Drugs Are Making the Mark?

Injectable Drugs: CDMOs/CMOs and Suppliers Expand

API Watch: Small Molecules

The Top 10 Deals for Pharma Innovation

Novel Excipients: Gaining Traction in the Industry

Re-configuring Global Pharma Supply Chains

2020 Vision: Digital Pharma—Beyond the Pill

A Top 10 Emerging Pharma Watch List

CDMOs Step Up to the COVID Challenge but Must Prepare for Uncertain Future

Tracking Expansion in High-Potency Manufacturing

DCAT Benchmarking Study Provides Insight into Supply-Chain Challenges

Pharma Company on the Move: The New AbbVie

Re-inventing US Pharma Mfg and Supply Chains

Supplying Potential COVID-19 Treatments & Vaccines

Drug Development in Wake of COVID-19

A Top 10 Watch List: Biologics and Biomanufacturing

Facilitating Sourcing in the Wake of COVID-19

COVID-19's Impact on Global Pharma Supply Chains

Indian Government Looks to Increase Domestic API Manufacturing

Drug Supply Chains and US-Based Manufacturing

Blockbuster Watch for 2020: New Market Entrants

Orphan Drugs: Bearing Revenue Gains or Not?

Emerging Biopharma Companies: Tracking Their Contribution to Innovation

20-20 Insights and Outlook for the CDMO Market